BioSpace News Archive

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the presentation of two abstracts at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting being held virtually from June 4-8, 2021.

Key leadership appointment adds expertise in strategic and technical aspects of pharmaceutical manufacturing to support ADP101, a broad-spectrum oral biopharmaceutical candidate targeting food allergy

As states continue to relax COVID-19 related restrictions, Beltone announced it will incorporate Clorox® products into its existing cleaning protocols at participating locations in North America to help provide what the company likes to call a “safe & sound” environment for in-person hearing care.

Scone Medical Solutions Inc announces that the United States Patent and Trademark Office has issued U.S. Patent No 10,967,204, which is directed to a system of creating a Self-Contained Negative Pressure Environment to remove airborne particulates from an environment.

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Charles Triano, Senior Vice President, Investor Relations, at the 7th Annual Truist Securities 2021 Life Sciences Summit on Wednesday, May 5, 2021 at 1:50 p.m. Eastern Daylight Time.

HighTide Therapeutics, a clinical-stage biopharmaceutical company focused on the development of innovative therapies for non-viral chronic liver diseases, gastrointestinal diseases, and metabolic disorders, announced that Company’s Management will provide a corporate presentation and participate in one-on-one investor meetings at the BofA Securities 2021 Health Care Conference to be held May 10-13, 2021.

Ultimovacs ASA (“Ultimovacs”, ticker ULTI) today announced that an abstract on the Company’s Phase I trial evaluating its universal cancer vaccine, UV1, in combination with the checkpoint inhibitor pembrolizumab in patients with metastatic malignant melanoma has been accepted for a poster presentation at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, announced that it will release first quarter 2021 financial results after the market closes on Wednesday, May 5, 2021.

CorWave, a French medical device company committed to the fight against heart failure, unveiled an unprecedented study on the performance of its implantable heart pump at the 41st Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT).